Cargando…

IMPACT OF INHALED CORTICOSTEROID USE ON OUTCOMES IN HOSPITALIZED PATIENTS WITH COVID-19 AND OBSTRUCTIVE LUNG DISEASES

Detalles Bibliográficos
Autores principales:	MARLIERE, MANUEL HACHE, J. HERNÁNDEZ ROMERO, GABRIEL, M REYES, FELIX, A. PALMARES, FRANCINE, ALEEM, HAMMAD, SCHWARTZ, DEBORAH, MCPHEE, CHRISTA, FERASTRAOARU, DENISA, REDDY, DIVYA
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American College of Chest Physicians. Published by Elsevier Inc. 2022
Materias:	Obstructive Lung Disease
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9548728/ http://dx.doi.org/10.1016/j.chest.2022.08.1567

Ejemplares similares

Use of inhaled corticosteroids and risk of acquiring Pseudomonas aeruginosa in patients with chronic obstructive pulmonary disease
por: Eklöf, Josefin, et al.
Publicado: (2022)

A COPD EXACERBATION THAT OCCURRED AFTER THE MRNA COVID-19 VACCINE
por: MUMM, TYLER, et al.
Publicado: (2021)

ACUTE COPD EXACERBATION AFTER THE SECOND DOSE OF COVID-19 VACCINE
por: DURDEVIC, MOMCILO, et al.
Publicado: (2021)

CLINICAL CONDITION AND SYMPTOMS OF PATIENTS WITH COPD WITH SARS-COV-2 INFECTION
por: BETANCOURT-PEñA, JHONATAN, et al.
Publicado: (2021)

SELF-REPORTED OUTCOMES FROM PATIENTS USING VEST THERAPY THROUGH THE COVID-RELATED REIMBURSEMENT CHANGES
por: BARTO, TARA, et al.
Publicado: (2021)

EFFECT OF DISCONTINUING NEBULIZER MAINTENANCE BROCHODILATOR THERAPY DURING THE COVID-19 PANDEMIC: A RETROSPECTIVE COHORT STUDY OF ELDERLY COPD PATIENTS RESIDING IN LONG-TERM CARE FACILITIES
por: NIU, XIAOLI, et al.
Publicado: (2021)

COVID-19 CHANGING RECOMMENDATIONS AND INFORMATION: THE IMPACT ON THE COPD COMMUNITY
por: PASQUALE, CARA, et al.
Publicado: (2021)

IMPACT OF THE COVID-19 PANDEMIC ON HOSPITAL ADMISSION RATE, LENGTH OF STAY, AND MORTALITY RATE FOR PATIENTS WITH COPD EXACERBATION: A RETROSPECTIVE STUDY
por: KOHLI, AKSHAY, et al.
Publicado: (2022)

Inhalation devices and inhaled corticosteroids particle size influence on severe pneumonia in patients with chronic obstructive pulmonary disease: a nationwide cohort study
por: Heerfordt, Christian Kjer, et al.
Publicado: (2023)

Inhaled corticosteroids and risk of lower respiratory tract infection with Moraxella catarrhalis in patients with chronic obstructive pulmonary disease
por: Johnsen, Rikke Helin, et al.
Publicado: (2023)

Inhaled corticosteroid dose is associated with Pseudomonas aeruginosa infection in severe COPD
por: Shafiek, Hanaa, et al.
Publicado: (2021)

Effect of inhaled corticosteroids on blood eosinophil count in steroid-naïve patients with COPD
por: Kreindler, James L, et al.
Publicado: (2016)

Blood eosinophils and inhaled corticosteroid/long-acting β-2 agonist efficacy in COPD
por: Pavord, Ian D, et al.
Publicado: (2016)

Characterisation of patients with chronic obstructive pulmonary disease initiating single-device inhaled corticosteroids/long-acting β(2)-agonist dual therapy in a primary care setting in England
por: Czira, Alexandrosz, et al.
Publicado: (2022)

Airway gene expression in COPD is dynamic with inhaled corticosteroid treatment and reflects biological pathways associated with disease activity
por: van den Berge, Maarten, et al.
Publicado: (2014)

Withdrawal of inhaled corticosteroids from patients with COPD with mild or moderate airflow limitation in primary care: a feasibility randomised trial
por: Harries, Timothy H, et al.
Publicado: (2022)

Efficacy and safety of once-daily single-inhaler triple therapy for mild-to-moderate chronic obstructive pulmonary disease: a study protocol for a randomised and interventional study
por: Takahashi, Koichiro, et al.
Publicado: (2023)

Th2 high and mast cell gene signatures are associated with corticosteroid sensitivity in COPD
por: Faiz, Alen, et al.
Publicado: (2023)

Cardiogenic Shock Secondary to Takotsubo Cardiomyopathy in a Patient with Preexisting Hypertrophic Obstructive Cardiomyopathy
por: Nalluri, Nikhil, et al.
Publicado: (2017)

Circulating testosterone levels and health outcomes in chronic obstructive pulmonary disease: results from ECLIPSE and ERICA
por: Pavey, Holly, et al.
Publicado: (2023)

Real-world use of rescue inhaler sensors, electronic symptom questionnaires and physical activity monitors in COPD
por: Bowler, Russell, et al.
Publicado: (2019)

COPD exacerbations: the impact of long versus short courses of oral corticosteroids on mortality and pneumonia: nationwide data on 67 000 patients with COPD followed for 12 months
por: Sivapalan, Pradeesh, et al.
Publicado: (2019)

Exploring the appropriateness of prescribing practice of inhaled pharmacotherapy among Aboriginal Australians in the Top End Northern Territory of Australia: a retrospective cohort study
por: Heraganahally, Subash, et al.
Publicado: (2023)

Plasma sphingolipids in HIV-associated chronic obstructive pulmonary disease
por: Hodgson, Shane, et al.
Publicado: (2017)

DNA methylation is associated with airflow obstruction in patients living with HIV
por: Hernandez Cordero, Ana I, et al.
Publicado: (2021)

Comorbidities and mortality among patients with chronic obstructive pulmonary disease
por: Skajaa, Nils, et al.
Publicado: (2023)

Small airway determinants of airflow limitation in chronic obstructive pulmonary disease
por: Polosukhin, Vasiliy V, et al.
Publicado: (2021)

Clinical validity of plasma and urinary desmosine as biomarkers for chronic obstructive pulmonary disease
por: Huang, Jeffrey T-J, et al.
Publicado: (2012)

Microbial contamination of domiciliary nebulisers and clinical implications in chronic obstructive pulmonary disease
por: Jarvis, S, et al.
Publicado: (2014)

Productivity losses in chronic obstructive pulmonary disease: a population-based survey
por: Erdal, Marta, et al.
Publicado: (2014)

Intravenous iron and chronic obstructive pulmonary disease: a randomised controlled trial
por: Santer, Peter, et al.
Publicado: (2020)

Eosinophilia and fractional exhaled nitric oxide levels in chronic obstructive lung disease
por: Annangi, Srinadh, et al.
Publicado: (2022)

Socio-environmental correlates of physical activity in patients with chronic obstructive pulmonary disease (COPD)
por: Arbillaga-Etxarri, Ane, et al.
Publicado: (2017)

Comparison of patient-reported outcomes during acute exacerbations of chronic obstructive pulmonary disease
por: Nishimura, Koichi, et al.
Publicado: (2018)

Frailty and patient-reported outcomes in subjects with chronic obstructive pulmonary disease: are they independent entities?
por: Kusunose, Masaaki, et al.
Publicado: (2017)

Metformin in severe exacerbations of chronic obstructive pulmonary disease: a randomised controlled trial
por: Hitchings, Andrew W, et al.
Publicado: (2016)

Cost-effectiveness of domiciliary non-invasive ventilation in patients with chronic obstructive pulmonary disease
por: Hall, James, et al.
Publicado: (2022)

Benefit–harm analysis of azithromycin for the prevention of acute exacerbations of chronic obstructive pulmonary disease
por: Ahmadian, Safa, et al.
Publicado: (2022)

Study design and rationale for the TETON phase 3, randomised, controlled clinical trials of inhaled treprostinil in the treatment of idiopathic pulmonary fibrosis
por: Nathan, Steven D, et al.
Publicado: (2022)

Randomised clinical trial to determine the safety of quercetin supplementation in patients with chronic obstructive pulmonary disease
por: Han, Meilan K, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_mgi2trq4pusmb7k0mb10sv9lmk